Advertisement
Advertisement
MDLN
Medline Inc. Class A common stock
39.76
USDSponsored
-0.59
-1.46%
Nov 05, 15:59 UTC -5
Closed
Pre-Market
39.60
-0.16
-0.39%
Medline Inc. Class A common stock (MDLN) Earnings
MDLN Earnings Reports
Positive Surprise Ratio
MDLN beat 4 of 4 last estimates.
100%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Medline Inc. Class A common stock earnings per share and revenue
On Nov 04, 2026, MDLN reported earnings of 0.44 USD per share (EPS) for Q3 26, beating the estimate of 0.35 USD, resulting in a 23.91% surprise. Revenue reached 7.86 billion, compared to an expected 7.88 billion, with a -0.27% difference. The market reacted with a +18.36% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Insulet Corporation
Report Date
Nov 04, 2026 For Q3 26
Estimate
$1.61
Actual
$1.99
Surprise
+22.95%
BillionToOne, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.14
Actual
$0.32
Surprise
+115.34%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
Phibro Animal Health Corporation Class A
Report Date
Nov 04, 2026 For Q1 27
Estimate
$0.81
Actual
$0.79
Surprise
-2.58%
Evolus, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.09
Surprise
-42.41%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
FAQ
What were Medline Inc. Class A common stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Medline Inc. Class A common stock reported EPS of $0.44, beating estimates by 23.91%, and revenue of $7.86B, -0.27% below expectations.
How did the market react to Medline Inc. Class A common stock's Q3 2026 earnings?
The stock price moved up 18.36%, changed from $34.09 before the earnings release to $40.35 the day after.
When is Medline Inc. Class A common stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Medline Inc. Class A common stock's next earnings report?
Based on --
analysts, Medline Inc. Class A common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.